Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Looking into the safety of AAV vectors.

Literature DB >> 12867952

Looking into the safety of AAV vectors.

Mark A Kay, Hiroyuki Nakai.

Abstract

Mesh：

Year: 2003 PMID： 12867952 DOI： 10.1038/424251b

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

Review 1. Recent developments and current status of gene therapy using viral vectors in the United Kingdom.

Authors: Kate Relph; Kevin Harrington; Hardev Pandha
Journal: BMJ Date: 2004-10-09

2. Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction.

Authors: Jinhui Wang; Jing Xie; Hui Lu; Lingxia Chen; Bernd Hauck; Richard Jude Samulski; Weidong Xiao
Journal: Proc Natl Acad Sci U S A Date: 2007-07-30 Impact factor: 11.205

3. Clinical therapeutics for phenylketonuria.

Authors: Jaspreet Singh Kochhar; Sui Yung Chan; Pei Shi Ong; Lifeng Kang
Journal: Drug Deliv Transl Res Date: 2012-08 Impact factor: 4.617

4. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver.

Authors: Hiroyuki Nakai; Xiaolin Wu; Sally Fuess; Theresa A Storm; David Munroe; Eugenio Montini; Shawn M Burgess; Markus Grompe; Mark A Kay
Journal: J Virol Date: 2005-03 Impact factor: 5.103

Review 5. New vectors and strategies for cardiovascular gene therapy.

Authors: Agnieszka Jazwa; Alicja Jozkowicz; Jozef Dulak
Journal: Curr Gene Ther Date: 2007-02 Impact factor: 4.391

6. Sensorimotor Cortex Injection of Adeno-Associated Viral Vector Mediates Knockout of PTEN in Neurons of the Brain and Spinal Cord of Mice.

Authors: Ping Yang; Yu Qin; Wen Zhang; Zhiqun Bian; Ruiqi Wang
Journal: J Mol Neurosci Date: 2015-07-11 Impact factor: 3.444

Looking into the safety of AAV vectors.

Review 1. Recent developments and current status of gene therapy using viral vectors in the United Kingdom.

2. Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction.

3. Clinical therapeutics for phenylketonuria.

4. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver.

Review 5. New vectors and strategies for cardiovascular gene therapy.

6. Sensorimotor Cortex Injection of Adeno-Associated Viral Vector Mediates Knockout of PTEN in Neurons of the Brain and Spinal Cord of Mice.

7. Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.

8. Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells.

Review 9. State-of-the-art 2003 on PKU gene therapy.

10. DNA-dependent PK inhibits adeno-associated virus DNA integration.